Listed

Spruce Biosciences, Inc.

SPRBNasdaqCIK 1683553HealthcareFiscal year ends Dec 31

Reports and events: 117 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Spruce Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2024-03-2821:15 ETSC 13D/AOwnership report, active investor, amended0001193125-24-081224
2024-03-2521:48 ETSC 13D/AOwnership report, active investor, amended0001193125-24-076792
2024-03-2021:31 ETSC 13D/AOwnership report, active investor, amended0001193125-24-073032
2024-03-1821:16 ETSC 13D/AOwnership report, active investor, amended0001193125-24-070413
2024-03-1816:05 ET10-KAnnual reportPeriod 2023-12-310000950170-24-032819
2024-03-1316:12 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-030776
2024-03-0716:07 ETSC 13D/AOwnership report, active investor, amended0001193125-24-062172
2024-01-0808:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-002704
2023-11-1316:22 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-062997
2023-11-1316:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-062936
2023-08-1416:20 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-042439
2023-08-1416:12 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-042420
2023-05-3016:48 ETSC 13D/AOwnership report, active investor, amended0001193125-23-156667
2023-05-2616:12 ET8-K5.07 Shareholder vote results0000950170-23-024515
2023-05-2508:16 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-024071
2023-05-1508:20 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021984
2023-05-1508:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-021979
2023-04-0516:10 ETDEF 14AProxy statementPeriod 2023-05-250000950170-23-011910
2023-03-1616:11 ET10-KAnnual reportPeriod 2022-12-310000950170-23-008456
2023-03-1616:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-008448
2023-02-2316:15 ETSC 13D/AOwnership report, active investor, amended0001193125-23-046574
2023-02-2116:28 ETSC 13D/AOwnership report, active investor, amended0001193125-23-043535
2023-02-1316:16 ETSC 13D/AOwnership report, active investor, amended0001193125-23-035842
2023-02-0916:33 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0000950170-23-002369
2023-01-0908:15 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-000449
2022-12-0217:27 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0000950170-22-026009
2022-11-1016:33 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-024531
2022-11-1016:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-024479
2022-09-3016:54 ETSC 13D/AOwnership report, active investor, amended0001193125-22-255669
2022-08-1116:50 ETSC 13D/AOwnership report, active investor, amended0001193125-22-218641
2022-08-1016:22 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016486
2022-08-1016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-016467
2022-05-2716:14 ET8-K5.07 Shareholder vote results0000950170-22-010856
2022-05-1116:13 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009335
2022-05-1116:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-009312
2022-04-0817:27 ET8-K5.02 Departure or appointment of officers or directors0000950170-22-005528
2022-04-0716:49 ETDEF 14AProxy statementPeriod 2022-05-250001140361-22-013615
2022-03-1416:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-003590
2022-03-1416:26 ET10-KAnnual reportPeriod 2021-12-310000950170-22-003582
2022-03-1416:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-003573
2022-01-0517:04 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-22-000432
2021-11-2216:08 ETSC 13D/AOwnership report, active investor, amended0001193125-21-336766
2021-11-1516:24 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-057024
2021-11-1516:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-057008
2021-09-1509:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-047979
2021-08-2511:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-045641
2021-08-1016:23 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-043111
2021-08-1016:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-043089
2021-06-2916:12 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-035079
2021-05-2416:37 ET8-K5.07 Shareholder vote results0001564590-21-029534

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.